DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2026)

DiaMedica Therapeutics (DMAC) has reported Other Non-Current Assets for 6 consecutive years, with $400000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Jun 2026 stood at $400000.0 (changed N/A YoY), and the FY2025 full-year result was $400000.0, down 69.42% from the prior year.
• Other Non-Current Assets held at $400000.0 in Q2 2026 per DMAC's latest filing, from $400000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.3 million in Q1 2024 and bottomed at $400000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $861000.0 across 3 years, with a median of $882000.0 in 2024.
• The widest YoY moves for Other Non-Current Assets: up 65.14% in 2025, down 69.42% in 2025.
• Over 3 years, Other Non-Current Assets stood at $1.3 million in 2024, then sank by 69.42% to $400000.0 in 2025, then changed by 0.0% to $400000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $400000.0, $400000.0, and $400000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.